InsidersTradesSigma
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Explore the complete record of transactions filed by Gros David-Alexandre C, 董事长兼首席执行官. Director active across 1 company, notably Eledon Pharmaceuticals, Inc.. In total, 5 reports have been published. Split: 3 buys · 0 sell. Total volume traded: €49k. Activity tracked since 9 June 2021. The latest transaction was filed on 31 July 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
David-Alexandre C. Gros is Chief Executive Officer at Eledon Pharmaceuticals, Inc. He leads the company and oversees all operations, ensuring compliance and financial performance. His leadership is essential for the growth and development of the organization.